Find new ideas and classic advice on strategy, innovation and leadership, for global leaders from the world's best business ...
The sNDA for AXS-05 for Alzheimer disease agitation includes findings from four phase 3 trials showing improved behaviors and delayed relapse.
And what to do about it by Thomas Keil and Marianna Zangrillo In their pursuit of strong performance, CEOs and executives often overlook a critical factor in organizational success: the health of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback